Skip to content

Clinical trials

Phase 2 Sjogren's Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sjogren's Syndrome Phase: Phase 2 Country / region: China Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20191
20211
20221
20241
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting2
Terminated2
Completed1
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Guang'anmen Hospital of China Academy of Chinese Medical Sciences1
Innovent Biologics (Suzhou) Co. Ltd.1
Peking Union Medical College Hospital1
Peking University People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sjogren's Syndrome7
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Antiphospholipid Syndrome1
Arthritis1
Autoimmune Diseases1
Behcet Syndrome1
Connective Tissue Diseases1
Dry Eye Syndromes1
Eye Diseases1
Immune System Diseases1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.